Inagene Diagnostics, in partnership with dnaPower, explores health through the lens of genetics, personalized medicine and prevention to help individuals make the best decisions to live their healthiest lives in the context of COVID-19.
Inagene Diagnostics in partnership with dnaPower, take a dive deep to inform consumers how their test results can be transformative in achieving their best health
Inagene Diagnostics Inc. is proud to attend the Canadian Pain Society webinar co-presented by our Chief Science Advisor, Katherine Siminovitch on November 10th
Nancy White, CEO of Inagene Diagnostics participated in a Panel Discussion at the 20th Annual Healthcare Summit (October 26-27, 2020), which focused on how COVID-19 is changing the private and public healthcare sector, both in terms of impacts as well as opportunities.
YummyMummy Club guest author reflects on her families difficult journey with opioid dependence, and shares her hope that pharmacogenetics can help more people avoid drug dependency and painful medication side effects.
